|
1
|
Knowles MA: Molecular pathogenesis of
bladder cancer. Int J Clin Oncol. 13:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choueiri TK and Raghavan D: Chemotherapy
for muscle-invasive bladder cancer treated with definitive
radiotherapy: Persisting uncertainties. Nat Clin Pract Oncol.
5:444–454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stein JP, Lieskovsky G, Cote R, Groshen S,
Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M,
et al: Radical cystectomy in the treatment of invasive bladder
cancer: Long-term results in 1,054 patients. J Clin Oncol.
19:666–675. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mayr R, Fritsche HM and Pycha A and Pycha
A: Radical cystectomy and the implications of comorbidity. Expert
Rev Anticancer Ther. 14:289–295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan X, Wang S, Zhu L, Wu C, Yin B, Zhao J,
Yuan J, Qiang B and Peng X: cAMP response element-binding protein
promotes gliomagenesis by modulating the expression of oncogenic
microRNA-23a. Proc Natl Acad Sci USA. 109:15805–15810. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gu L, Lu LS, Zhou DL and Liu ZC: UCA1
promotes cell proliferation and invasion of gastric cancer by
targeting CREB1 sponging to miR-590-3p. Cancer Med. 7:1253–1263.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Lang T, Jin B, Chen F, Zhang Y,
Beuerman RW, Zhou L and Zhang Z: Luteolin inhibits colorectal
cancer cell epithelial-to-mesenchymal transition by suppressing
CREB1 expression revealed by comparative proteomics study. J
Proteomics. 161:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dimitrova N, Nagaraj AB, Razi A, Singh S,
Kamalakaran S, Banerjee N, Joseph P, Mankovich A, Mittal P, DiFeo
A, et al: InFlo: A novel systems biology framework identifies
cAMP-CREB1 axis as a key modulator of platinum resistance in
ovarian cancer. Oncogene. 36:2472–2482. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu J, Zou Z, Nie P, Kou X, Wu B, Wang S,
Song Z and He J: Downregulation of microRNA-27b-3p enhances
tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1
expression. Cell Death Dis. 7:e24542016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye Q, Su L, Chen D, Zheng W and Liu Y:
Astragaloside IV induced miR-134 expression reduces EMT and
increases chemotherapeutic sensitivity by suppressing CREB1
signaling in colorectal cancer cell line SW-480. Cell Physiol
Biochem. 43:1617–1626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang S, Wang X, Li J, Meng S, Liang Z, Xu
X, Zhu Y, Li S, Wu J, Xu M, et al: c-Met, CREB1 and EGFR are
involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail
signaling in prostate cancer. Oncotarget. 8:82303–82313.
2017.PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ying SY, Chang DC and Lin SL: The microRNA
(miRNA): Overview of the RNA genes that modulate gene function. Mol
Biotechnol. 38:257–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao L, Yan P, Guo FF, Liu HJ and Zhao ZF:
MiR-1-3p inhibits cell proliferation and invasion by regulating
BDNF-TrkB signaling pathway in bladder cancer. Neoplasma. 65:89–96.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhai X and Xu W: Long noncoding RNA ATB
promotes proliferation, migration and invasion in bladder cancer by
suppressing microRNA-126. Oncol Res. 2018.(Epub ahead of print).
https://doi.org/10.3727/096504018×15152072098476
View Article : Google Scholar
|
|
16
|
Zhang L, Xu J, Yang G, Li H and Guo X:
miR-202 inhibits cell proliferation, migration, and invasion by
targeting EGFR in human bladder cancer. Oncol Res. 2018.(Epub ahead
of print). https://doi.org/10.3727/096504018×15149787144385
View Article : Google Scholar
|
|
17
|
Yang D, Du G, Xu A, Xi X and Li D:
Expression of miR-149-3p inhibits proliferation, migration, and
invasion of bladder cancer by targeting S100A4. Am J Cancer Res.
7:2209–2219. 2017.PubMed/NCBI
|
|
18
|
Qian J, Li R, Wang YY, Shi Y, Luan WK, Tao
T, Zhang JX, Xu YC and You YP: MiR-1224-5p acts as a tumor
suppressor by targeting CREB1 in malignant gliomas. Mol Cell
Biochem. 403:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Ma Y, Wang S, Chen F and Gu Y:
C/EBPα inhibits proliferation of breast cancer cells via a novel
pathway of miR-134/CREB. Int J Clin Exp Pathol. 8:14472–14478.
2015.PubMed/NCBI
|
|
20
|
Rao M, Zhu Y, Zhou Y, Cong X and Feng L:
MicroRNA-122 inhibits proliferation and invasion in gastric cancer
by targeting CREB1. Am J Cancer Res. 7:323–333. 2017.PubMed/NCBI
|
|
21
|
Pop-Bica C, Gulei D, Cojocneanu-Petric R,
Braicu C, Petrut B and Berindan-Neagoe I: Understanding the role of
non-coding RNAs in bladder cancer: From dark matter to valuable
therapeutic targets. Int J Mol Sci. 18:E15142017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin Y, Wang J, Han J, Luo D and Sun Z:
MiR-122 inhibits epithelial-mesenchymal transition in
hepatocellular carcinoma by targeting Snail1 and Snail2 and
suppressing WNT/β-cadherin signaling pathway. Exp Cell Res.
360:210–217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maierthaler M, Benner A, Hoffmeister M,
Surowy H, Jansen L, Knebel P, Chang-Claude J, Brenner H and
Burwinkel B: Plasma miR-122 and miR-200 family are prognostic
markers in colorectal cancer. Int J Cancer. 140:176–187. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Xing QF, Liu XQ, Guo ZJ, Li CY and
Sun G: miR-122 targets VEGFC in bladder cancer to inhibit tumor
growth and angiogenesis. Am J Transl Res. 8:3056–3066.
2016.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sunkel B, Wu D, Chen Z, Wang CM, Liu X, Ye
Z, Horning AM, Liu J, Mahalingam D, Lopez-Nicora H, et al:
Integrative analysis identifies targetable CREB1/FoxA1
transcriptional co-regulation as a predictor of prostate cancer
recurrence. Nucleic Acids Res. 44:4105–4122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu X, Zhu Y, Liang Z, Li S, Xu X, Wang X,
Wu J, Hu Z, Meng S, Liu B, et al: c-Met and CREB1 are involved in
miR-433-mediated inhibition of the epithelial-mesenchymal
transition in bladder cancer by regulating Akt/GSK-3/Snail
signaling. Cell Death Dis. 7:e20882016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shabestari RM, Safa M, Alikarami F, Banan
M and Kazemi A: CREB knockdown inhibits growth and induces
apoptosis in human pre-B acute lymphoblastic leukemia cells through
inhibition of prosurvival signals. Biomed Pharmacother. 87:274–279.
2017. View Article : Google Scholar : PubMed/NCBI
|
